These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33542199)

  • 1. Metabolomics reveals biomarkers of opioid use disorder.
    Ghanbari R; Li Y; Pathmasiri W; McRitchie S; Etemadi A; Pollock JD; Poustchi H; Rahimi-Movaghar A; Amin-Esmaeili M; Roshandel G; Shayanrad A; Abaei B; Malekzadeh R; Sumner SCJ
    Transl Psychiatry; 2021 Feb; 11(1):103. PubMed ID: 33542199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Problematizing the DSM-5 criteria for opioid use disorder: A qualitative analysis.
    Boyd S; Ivsins A; Murray D
    Int J Drug Policy; 2020 Apr; 78():102690. PubMed ID: 32278265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of treatment by Medicaid enrollees with opioid use disorder and co-occurring substance use disorders.
    O'Brien P; Henke RM; Schaefer MB; Lin J; Creedon TB
    Drug Alcohol Depend; 2020 Dec; 217():108261. PubMed ID: 32979735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Probable Opioid Use Disorder Using Electronic Health Record Documentation.
    Palumbo SA; Adamson KM; Krishnamurthy S; Manoharan S; Beiler D; Seiwell A; Young C; Metpally R; Crist RC; Doyle GA; Ferraro TN; Li M; Berrettini WH; Robishaw JD; Troiani V
    JAMA Netw Open; 2020 Sep; 3(9):e2015909. PubMed ID: 32886123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying individuals with opioid use disorder: Validity of International Classification of Diseases diagnostic codes for opioid use, dependence and abuse.
    Lagisetty P; Garpestad C; Larkin A; Macleod C; Antoku D; Slat S; Thomas J; Powell V; Bohnert ASB; Lin LA
    Drug Alcohol Depend; 2021 Apr; 221():108583. PubMed ID: 33662670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing engagement and utilisation of opium tincture-assisted treatment for opioid use disorder: A qualitative study in Tehran, Iran.
    Noroozi A; Conigrave KM; Mirrahimi B; Bastani P; Charkhgard N; Salehi M; Narenjiha H; Vaziri A; Kebriaeezadeh A
    Drug Alcohol Rev; 2022 Feb; 41(2):419-429. PubMed ID: 34309108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
    Sohn M; Talbert JC; Huang Z; Oser C; Freeman PR
    Pain Physician; 2021 Mar; 24(2):E249-E256. PubMed ID: 33740362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Untargeted Metabolomics: Biochemical Perturbations in Golestan Cohort Study Opium Users Inform Intervention Strategies.
    Li YY; Ghanbari R; Pathmasiri W; McRitchie S; Poustchi H; Shayanrad A; Roshandel G; Etemadi A; Pollock JD; Malekzadeh R; Sumner SCJ
    Front Nutr; 2020; 7():584585. PubMed ID: 33415121
    [No Abstract]   [Full Text] [Related]  

  • 9. Arguments for and Against a New Diagnostic Entity for Patients With Chronic Pain on Long-Term Opioid Therapy for Whom Harms Outweigh Benefits.
    Edmond SN; Snow JL; Pomeranz J; Van Cleve R; Becker WC
    J Pain; 2022 Jun; 23(6):958-966. PubMed ID: 34974174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Variants Associated With Opioid Use Disorder.
    Freiermuth CE; Kisor DF; Lambert J; Braun R; Frey JA; Bachmann DJ; Bischof JJ; Lyons MS; Pantalon MV; Punches BE; Ancona R; Sprague JE
    Clin Pharmacol Ther; 2023 May; 113(5):1089-1095. PubMed ID: 36744646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in prior receipt of prescription opioid or adjuvant analgesics among patients with incident opioid use disorder or opioid-related overdose from 2006 to 2016.
    Wei YJ; Chen C; Schmidt SO; LoCiganic WH; Winterstein AG
    Drug Alcohol Depend; 2019 Nov; 204():107600. PubMed ID: 31586806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "I'm a Survivor": Perceptions of Chronic Disease and Survivorship Among Individuals in Long-Term Remission from Opioid Use Disorder.
    Pytell JD; Sklar MD; Carrese J; Rastegar DA; Gunn C; Chander G
    J Gen Intern Med; 2022 Feb; 37(3):593-600. PubMed ID: 34027611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and treatment of opioid use disorders among primary care patients in six health systems.
    Lapham G; Boudreau DM; Johnson EA; Bobb JF; Matthews AG; McCormack J; Liu D; Samet JH; Saxon AJ; Campbell CI; Glass JE; Rossom RC; Murphy MT; Binswanger IA; Yarborough BJH; Bradley KA;
    Drug Alcohol Depend; 2020 Feb; 207():107732. PubMed ID: 31835068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Opioid Use Disorder Treatment With Alcohol-Related Acute Events.
    Xu KY; Presnall N; Mintz CM; Borodovsky JT; Bhat NR; Bierut LJ; Grucza RA
    JAMA Netw Open; 2021 Feb; 4(2):e210061. PubMed ID: 33625511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population.
    Morgan JR; Schackman BR; Leff JA; Linas BP; Walley AY
    J Subst Abuse Treat; 2018 Feb; 85():90-96. PubMed ID: 28733097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cascade of care for opioid use disorder among youth in British Columbia, 2018.
    Krebs E; Min JE; Zhou H; Davison C; McGowan G; Nosyk B
    J Subst Abuse Treat; 2021 Nov; 130():108404. PubMed ID: 34118696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric comorbidity and order of condition onset among patients seeking treatment for chronic pain and opioid use disorder.
    Barry DT; Beitel M; Cutter CJ; Fiellin DA; Madden LM; Lipkind N; Bollampally P; Liong C; Schottenfeld RS
    Drug Alcohol Depend; 2021 Apr; 221():108608. PubMed ID: 33667784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospectively assessed subjective effects of initial opioid use differ between opioid misusers with opioid use disorder (OUD) and those who never progressed to OUD: Data from a pilot and a replication sample.
    Agrawal A; Jeffries PW; Srivastava AB; McCutcheon VV; Lynskey MT; Heath AC; Nelson EC
    J Neurosci Res; 2022 Jan; 100(1):353-361. PubMed ID: 32468677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic Opioid Misuse and Opioid Use Disorder among Patients with Chronic Non-Cancer Pain and Prescribed Opioids in a Pain Centre in France.
    Guillou-Landreat M; Quinio B; Le Reste JY; Le Goff D; Fonsecca J; Grall-Bronnec M; Dany A
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33670004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age of initiation, psychopathology, and other substance use are associated with time to use disorder diagnosis in persons using opioids nonmedically.
    Schepis TS; Hakes JK
    Subst Abus; 2017; 38(4):407-413. PubMed ID: 28723266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.